相关实验视频
Updated: Jul 6, 2025

07:14
Acupuncture in a Rat Model of Asthma
Published on: August 25, 2020
6.0K
通过"剂量效应加权系数"探索Belamcanda Chinensis的喘机制 网络药理学和实验验证
Kaiyue Zhang1, Jingwei Lv1, Jiaming Shen1
1Department of Jilin Institute of Ginseng Science, Changchun University of Chinese Medicine, Changchun 130114, China.
Combinatorial chemistry & high throughput screening
|December 29, 2023
概括
贝拉姆坎达中国菌 (BC) 通过网络药理学识别关键标和活性化合物,显示出对喘的保护作用. 这项研究为选天然产品成分用于喘治疗提供了一种新的方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传统中国医药 传统中国医药
- 网络药理学 网络药理学
背景情况:
- 喘是一种慢性呼吸道炎症疾病,对健康有重大影响.
- 贝拉姆坎达中药 (BC) 是一种传统的中医药,具有与喘治疗相关的抗炎和免疫调节性质.
研究的目的:
- 为了研究贝拉姆坎达中国 (BC) 在治疗喘中的作用机制.
- 建立一个"剂量效应加权系数"网络药理学方法来预测活性化合物.
主要方法:
- 使用UPLC-QEOrbitrap-MS光谱测量来分析BC组件.
- 网络药理学方法集成了BC含量,生物可用性和分子对接,以确定关键目标和途径.
- MTT和ELISA测定验证了活性成分对16HBE细胞增殖的影响.
主要成果:
- 贝拉姆坎达中国 (BC) 在16HBE喘模型上显示出保护作用.
- 确定的主要目标包括SYK,AKT1和ALOX5,其中FcepsilonRI作为一个重要的信号通路.
- 确定了8种活性化合物,包括tctoridin和mangiferin,其中5种促进16HBE细胞增殖,并作为潜在的质量标志物.
结论:
- 这项研究提出了一种新的虚拟和实用的方法,用于快速选天然产品中的活性成分.
- 这些发现支持使用Belamcanda chinensis (BC) 治疗喘,并提供潜在的质量标志物.
相关概念视频
Antiasthma Drugs: β2-Adrenoceptor Agonists
267
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
267
Asthma: Pathogenesis and Management
405
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
405
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
301
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
301
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Methylxanthines
231
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
231

